TY  - JOUR

T1  - Rivaroxaban for Preventing Atherothrombotic Events in People with Acute Coronary Syndrome and Elevated Cardiac Biomarkers: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

JO  - Pharmacoeconomics

UR  - https://eprints.whiterose.ac.uk/id/eprint/93179

UR  - http://dx.doi.org/10.1007/s40273-015-0351-2

PY  - 2015/12/21

AU  - Pandor A

AU  - Pollard D

AU  - Chico T

AU  - Henderson R

AU  - Stevenson M

ED  - 

DO  - DOI: 10.1007/s40273-015-0351-2

PB  - Springer Verlag

Y2  - 2025/04/29

ER  -